Differences between imported drugs and domestic drugs of lenvatinib/lenvatinib (Lenvima)

Lenvatinib is a multi-target receptor tyrosine kinase inhibitor widely used in the treatment of renal cell carcinoma, hepatocellular carcinoma, thyroid cancer and endometrial cancer. With its popularity in the international market, there are certain differences between imported drugs and drugs on the domestic market, mainly reflected in aspects such as source, price, policy and packaging, but they are basically the same in terms of drug ingredients and clinical efficacy.

The original imported lenvatinib has undergone strict international drug regulatory approval and has globally unified quality standards and stability verification. In the domestic market, original drugs are produced and sold under authorization or cooperation from international pharmaceutical companies, and their quality control, active ingredients and specifications remain consistent with overseas versions. Imported drugs are usually consistent with the international version in terms of packaging, drug instructions, and approved indications, and their prices are relatively high in the initial stage of marketing, mainly due to factors such as transportation, tariffs, and import costs.

At the same time, there are also generic versions on the market in China. These generic drugs are produced by local pharmaceutical companies and have been approved by the Food and Drug Administration. Their main drug ingredients are the same as the original drugs, the dosage specifications are consistent, and they can meet the same clinical use needs. The price of generic drugs is usually lower than that of imported original drugs, which provides domestic patients with a more economical choice while maintaining continuity of treatment and stability of efficacy. The launch of generic drugs has also further promoted the coverage of domestic medical insurance policies, allowing more patients to obtain less burdensome treatment options through medical insurance.

From the perspective of user experience, whether it is an imported original drug or a domestic generic drug, both are in capsule form and can be taken at a fixed time every day. There is no essential difference between the two in terms of medication guidance, monitoring and side effect management. Both require attention to liver function, blood pressure, thyroid function and bleeding risk. When patients choose drugs, they can decide whether to use imported drugs or domestic generic drugs based on economic conditions, medical insurance coverage and doctor's advice.

Reference materials:https://www.lenvima.com/